Stockreport

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF KELOWNA, BC / ACCESS Newswire / February 24, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delive [Read more]